184 related articles for article (PubMed ID: 10540936)
1. Extracorporeal photochemotherapy for cutaneous T-cell lymphoma: a 9.7-year experience.
Jiang SB; Dietz SB; Kim M; Lim HW
Photodermatol Photoimmunol Photomed; 1999 Oct; 15(5):161-5. PubMed ID: 10540936
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis for the treatment of erythrodermic cutaneous T-cell lymphoma: a single center clinical experience with long-term follow-up data and a brief overview of the literature.
Quaglino P; Knobler R; Fierro MT; Savoia P; Marra E; Fava P; Bernengo MG
Int J Dermatol; 2013 Nov; 52(11):1308-18. PubMed ID: 23786842
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photochemotherapy--the Columbia Presbyterian experience.
Knobler E; Warmuth I; Cocco C; Miller B; Mackay J
Photodermatol Photoimmunol Photomed; 2002 Oct; 18(5):232-7. PubMed ID: 12390664
[TBL] [Abstract][Full Text] [Related]
4. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy.
Heald P; Rook A; Perez M; Wintroub B; Knobler R; Jegasothy B; Gasparro F; Berger C; Edelson R
J Am Acad Dermatol; 1992 Sep; 27(3):427-33. PubMed ID: 1401279
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with cutaneous T-cell lymphoma treated with extracorporeal photochemotherapy.
Zic JA; Stricklin GP; Greer JP; Kinney MC; Shyr Y; Wilson DC; King LE
J Am Acad Dermatol; 1996 Dec; 35(6):935-45. PubMed ID: 8959953
[TBL] [Abstract][Full Text] [Related]
6. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.
Gottlieb SL; Wolfe JT; Fox FE; DeNardo BJ; Macey WH; Bromley PG; Lessin SR; Rook AH
J Am Acad Dermatol; 1996 Dec; 35(6):946-57. PubMed ID: 8959954
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma--the Düsseldorf and Munich experience.
Prinz B; Behrens W; Hölzle E; Plewig G
Arch Dermatol Res; 1995; 287(7):621-6. PubMed ID: 8534123
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.
Bisaccia E; Gonzalez J; Palangio M; Schwartz J; Klainer AS
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):263-71. PubMed ID: 10906649
[TBL] [Abstract][Full Text] [Related]
10. Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma.
Zic J; Arzubiaga C; Salhany KE; Parker RA; Wilson D; Stricklin GP; Greer J; King LE
J Am Acad Dermatol; 1992 Nov; 27(5 Pt 1):729-36. PubMed ID: 1430395
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.
Suchin KR; Cucchiara AJ; Gottleib SL; Wolfe JT; DeNardo BJ; Macey WH; Bromley PG; Vittorio CC; Rook AH
Arch Dermatol; 2002 Aug; 138(8):1054-60. PubMed ID: 12164743
[TBL] [Abstract][Full Text] [Related]
12. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
13. Extracorporeal photopheresis--a new approach for the treatment of cutaneous T cell lymphomas.
Gollnick HP; Owsianowski M; Ramaker J; Chun SC; Orfanos CE
Recent Results Cancer Res; 1995; 139():409-15. PubMed ID: 7597308
[TBL] [Abstract][Full Text] [Related]
14. Photopheresis therapy for cutaneous T-cell lymphoma.
Duvic M; Hester JP; Lemak NA
J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
[TBL] [Abstract][Full Text] [Related]
15. Photopheresis for the treatment of cutaneous T cell lymphoma.
Armus S; Keyes B; Cahill C; Berger C; Crater D; Scarborough D; Klainer A; Bisaccia E
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):898-902. PubMed ID: 2147701
[TBL] [Abstract][Full Text] [Related]
16. The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4(+) Foxp3(+) CD25(-) T cells in patients with leukemic cutaneous T-cell lymphoma.
Shiue LH; Couturier J; Lewis DE; Wei C; Ni X; Duvic M
Photodermatol Photoimmunol Photomed; 2015 Jul; 31(4):184-94. PubMed ID: 25772268
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with cutaneous T-cell lymphoma after treatment with extracorporeal photochemotherapy.
Wollina U; Liebold K; Kaatz M; Looks A; Stuhlert A; Lange D
Oncol Rep; 2000; 7(6):1197-201. PubMed ID: 11032913
[TBL] [Abstract][Full Text] [Related]
18. Etretinate as an effective adjunctive therapy for recalcitrant palmar/plantar hyperkeratosis in patients with erythrodermic cutaneous T cell lymphoma undergoing photopheresis.
Lim HW; Harris HR
Dermatol Surg; 1995 Jul; 21(7):597-9. PubMed ID: 7606369
[TBL] [Abstract][Full Text] [Related]
19. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
Seremet S; Abhyankar S; Herd TJ; Aires D
J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338
[TBL] [Abstract][Full Text] [Related]
20. Photopheresis for the treatment of cutaneous T-cell lymphoma.
Lim HW; Edelson RL
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]